Your session is about to expire
← Back to Search
Behavioral Intervention
DTTC with Caregiver Training for Childhood Apraxia of Speech (DTTC Trial)
N/A
Recruiting
Research Sponsored by New York University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
2;6-7;11 years of age at the start of treatment
Primary speech diagnosis of Childhood Apraxia of Speech (CAS) based on auditory-perceptual, expert diagnosis and/or Dynamic Evaluation of Motor Speech Skills (DEMSS) score classification of 'significant evidence of CAS' with score <323
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre- to post-treatment (16 treatment sessions over 8 weeks); 1-week and 4-week post-treatment follow-up
Awards & highlights
DTTC Trial Summary
This trial will test how training caregivers affects treatment of childhood apraxia of speech. 40 kids will be coached on speech at 2x/week for 8 weeks, while their caregivers are trained. Outcomes will be compared.
Who is the study for?
This trial is for children aged between 2 years and 5 months to 7 years and 11 months with a primary diagnosis of Childhood Apraxia of Speech (CAS) who speak English as their main language. Kids with autism, global developmental delay, Down syndrome, or severe hearing or visual impairments can't join. Those already receiving speech treatment elsewhere are also excluded.Check my eligibility
What is being tested?
The study tests the effects of caregiver training on DTTC therapy outcomes in kids with CAS. Forty children will receive standard DTTC treatments twice weekly at a clinic over eight weeks. They'll be split into two groups: one gets direct coaching for home practice; the other doesn't.See study design
What are the potential side effects?
Since this trial involves speech therapy techniques rather than medication, there aren't typical drug side effects. However, it's possible that participants may experience frustration or fatigue from intensive practice sessions.
DTTC Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 2 and 11 years old.
Select...
I have been diagnosed with Childhood Apraxia of Speech.
DTTC Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre- to post-treatment (16 treatment sessions over 8 weeks); 1-week and 4-week post-treatment follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre- to post-treatment (16 treatment sessions over 8 weeks); 1-week and 4-week post-treatment follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes in word accuracy
Secondary outcome measures
Changes in phoneme accuracy
Changes in speech intelligibility
Changes in the FOCUS-34 score
DTTC Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Direct Training (DTTC + Coaching + Home Practice)Experimental Treatment1 Intervention
Children in the Direct Training Arm will receive DTTC treatment 2x/week for 8 weeks with half of each session administered only by the SLP. In the other half of the session, DTTC will be administered by the parent/caregiver with online coaching by the SLP. During the coaching portion of treatment sessions, the SLP will provide direct training to guide the parent/caregiver in the administration of DTTC to support home practice sessions. Parent/caregivers in this Arm will also complete an online, self-paced educational module on CAS prior to the start of treatment and review home practice guidelines with the clinician at the end of each therapy session. Parent/caregivers will engage their children in home practice during the treatment phase and follow-up phase. Home practice will consist of 30-minute practice sessions 3x/week during the 8-week treatment phase and 6x/week during the 4-week follow-up phase.
Group II: Indirect Training (DTTC + Home Practice)Active Control1 Intervention
Children in the Indirect Training Arm will receive DTTC treatment 2x/week administered by an SLP for 8 weeks. Parent/caregivers in this Arm will complete an online, self-paced educational module on CAS prior to the start of treatment, observe all treatment sessions, and review home practice guidelines with the clinician at the end of each therapy session. Parent/caregivers will engage their children in home practice during the treatment phase and follow-up phase. Home practice will consist of 30-minute practice sessions 3x/week during the 8-week treatment phase and 6x/week during the 4-week follow-up phase.
Find a Location
Who is running the clinical trial?
Hofstra UniversityOTHER
4 Previous Clinical Trials
238 Total Patients Enrolled
1 Trials studying Childhood Apraxia of Speech
60 Patients Enrolled for Childhood Apraxia of Speech
New York UniversityLead Sponsor
226 Previous Clinical Trials
314,077 Total Patients Enrolled
2 Trials studying Childhood Apraxia of Speech
132 Patients Enrolled for Childhood Apraxia of Speech
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 2 and 11 years old.I am not receiving speech therapy from another provider during this study, but I may be getting language or AAC therapy.I have hearing loss.I have been diagnosed with a speech disorder.I have abnormalities in the structure of my mouth.My child's cognitive score is below 70, indicating a significant delay.Your language test scores are lower than 70 on tests like REEL-4, CELF-P3, or CELF-5.I have vision problems that glasses or contacts can't fix.I have a condition like autism, Down syndrome, or similar, but can focus in sessions with help.I have been diagnosed with Childhood Apraxia of Speech.
Research Study Groups:
This trial has the following groups:- Group 1: Direct Training (DTTC + Coaching + Home Practice)
- Group 2: Indirect Training (DTTC + Home Practice)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this trial consider elderly individuals older than 85 years to be potential participants?
"According to the criteria set forth for this experiment, it is necessary that potential participants are between 24 and 95 months of age."
Answered by AI
How many people can potentially join the ongoing clinical experiment?
"Affirmative, the clinical trial is currently recruiting. Clinicaltrials.gov records indicate that this experiment was posted on July 19th of 2023 and revised most recently on the 24th. The investigation requires 40 individuals at two sites to participate."
Answered by AI
Is enrollment still available for this research endeavor?
"Affirmative. Information from clinicaltrials.gov suggests that this study is actively recruiting patients - it was initially posted on July 19th 2023 and its most recent update occurred on the 24th of last month. This trial needs to enroll 40 individuals across two locations for completion."
Answered by AI
Who is eligible to enroll in this clinical investigation?
"This medical trial is looking to enrol 40 children, aged between two years and eight months up to 95 months old, diagnosed with Childhood Apraxia of Speech. In addition to the age criteria, participants must be able to communicate in English as their primary language; additionally they need an expert diagnosis or a Dynamic Evaluation of Motor Speech Skills (DEMSS) score that indicates ‘significant evidence’ of CAS for eligibility consideration."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger